Skip to main content
Article thumbnail
Location of Repository

Mapping Gene Associations in Human Mitochondria using Clinical Disease Phenotypes

By Curt Scharfe, Henry Horng-Shing Lu, Jutta K. Neuenburg, Edward A. Allen, Guan-Cheng Li, Thomas Klopstock, Tina M. Cowan, Gregory M. Enns and Ronald W. Davis

Abstract

Nuclear genes encode most mitochondrial proteins, and their mutations cause diverse and debilitating clinical disorders. To date, 1,200 of these mitochondrial genes have been recorded, while no standardized catalog exists of the associated clinical phenotypes. Such a catalog would be useful to develop methods to analyze human phenotypic data, to determine genotype-phenotype relations among many genes and diseases, and to support the clinical diagnosis of mitochondrial disorders. Here we establish a clinical phenotype catalog of 174 mitochondrial disease genes and study associations of diseases and genes. Phenotypic features such as clinical signs and symptoms were manually annotated from full-text medical articles and classified based on the hierarchical MeSH ontology. This classification of phenotypic features of each gene allowed for the comparison of diseases between different genes. In turn, we were then able to measure the phenotypic associations of disease genes for which we calculated a quantitative value that is based on their shared phenotypic features. The results showed that genes sharing more similar phenotypes have a stronger tendency for functional interactions, proving the usefulness of phenotype similarity values in disease gene network analysis. We then constructed a functional network of mitochondrial genes and discovered a higher connectivity for non-disease than for disease genes, and a tendency of disease genes to interact with each other. Utilizing these differences, we propose 168 candidate genes that resemble the characteristic interaction patterns of mitochondrial disease genes. Through their network associations, the candidates are further prioritized for the study of specific disorders such as optic neuropathies and Parkinson disease. Most mitochondrial disease phenotypes involve several clinical categories including neurologic, metabolic, and gastrointestinal disorders, which might indicate the effects of gene defects within the mitochondrial system. The accompanying knowledgebase (http://www.mitophenome.org/) supports the study of clinical diseases and associated genes

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2668170
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • http://www.mitophenome.org/) (external link)
  • Suggested articles

    Citations

    1. (2005). 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an Xlinked inborn error of isoleucine metabolism that may mimic a mitochondrial disease.
    2. (2004). 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease.
    3. (2008). A collaborative knowledge base for cognitive phenomics.
    4. (2007). A human phenome-interactome network of protein complexes implicated in genetic disorders.
    5. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.
    6. (2005). A network-based analysis of systemic inflammation in humans.
    7. (2006). A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.
    8. (2003). A role for mitochondrial enzymes in inherited neoplasia and beyond.
    9. (2006). A text-mining analysis of the human phenome.
    10. (2007). Building the power house: recent advances in mitochondrial studies through proteomics and systems biology.
    11. (2008). Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation.
    12. (2002). Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency.
    13. (2006). Creation and implications of a phenome-genome network.
    14. (2005). Data mining : practical machine learning tools and techniques.
    15. (2005). Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.
    16. (2001). Epidemiology and treatment of mitochondrial disorders.
    17. (2004). From syndrome families to functional genomics.
    18. (2002). Functional profiling of the Saccharomyces cerevisiae genome.
    19. (2007). Geneexpression variation within and among human populations.
    20. (2003). Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics.
    21. (2004). Integrative analysis of the mitochondrial proteome in yeast.
    22. (2005). Mapping phenotypes to language: a proposal to organize and standardize the clinical descriptions of malformations.
    23. (1971). Metabolic rate and organ size during growth from infancy to maturity and during late gastation and early infancy. Pediatrics 47: Suppl 2:
    24. (2003). Minimum birth prevalence of mitochondrial respiratory chain disorders in children.
    25. (2005). Mitochondrial dysfunction and type 2 diabetes.
    26. (2006). MitoP2: the mitochondrial proteome database–now including mouse data.
    27. (2003). Molecular pathways of neurodegeneration in Parkinson’s disease.
    28. (2006). MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion.
    29. (1998). Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency.
    30. (2008). Network properties of genes harboring inherited disease mutations.
    31. (2008). Networking metabolites and diseases.
    32. (2002). Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells.
    33. (1998). Nuclear power and mitochondrial disease.
    34. (2005). Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.
    35. (2005). Phenome’’ project set to pin down subgroups of autism.
    36. (2006). Physiological diversity of mitochondrial oxidative phosphorylation.
    37. (2006). Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes.
    38. (1981). Sequence and organization of the human mitochondrial genome.
    39. (2006). Systematic identification of human mitochondrial disease genes through integrative genomics.
    40. (2002). Systematic screen for human disease genes in yeast.
    41. (2007). The bipolar disorder phenome database: a resource for genetic studies.
    42. (2003). The contribution of mitochondria to common disorders.
    43. (1994). The development of mitochondrial medicine.
    44. (2007). The human disease network.
    45. (2003). The human phenome project.
    46. (2001). The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities.
    47. (2008). The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.